UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1296) 1296
Book Chapter (42) 42
Dissertation (12) 12
Conference Proceeding (3) 3
Publication (2) 2
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lapatinib (1245) 1245
science & technology (963) 963
life sciences & biomedicine (925) 925
humans (829) 829
oncology (673) 673
female (607) 607
breast cancer (590) 590
trastuzumab (500) 500
breast neoplasms - drug therapy (448) 448
her2 (333) 333
skin and connective tissue diseases (306) 306
receptor, erbb-2 - metabolism (282) 282
cancer (272) 272
breast neoplasms - pathology (267) 267
quinazolines - administration & dosage (266) 266
antineoplastic agents - therapeutic use (259) 259
middle aged (242) 242
receptor, erbb-2 - antagonists & inhibitors (238) 238
quinazolines - therapeutic use (232) 232
cell line, tumor (230) 230
antineoplastic combined chemotherapy protocols - therapeutic use (209) 209
breast neoplasms - metabolism (209) 209
quinazolines - pharmacology (205) 205
aged (196) 196
pharmacology & pharmacy (190) 190
adult (186) 186
animals (183) 183
epidermal growth factor (177) 177
care and treatment (161) 161
metastasis (161) 161
antineoplastic agents - pharmacology (160) 160
chemotherapy (160) 160
treatment outcome (159) 159
receptor, erbb-2 - genetics (148) 148
antineoplastic agents (144) 144
medicine & public health (139) 139
research (132) 132
breast neoplasms - genetics (129) 129
antimitotic agents (125) 125
quinazolines - adverse effects (121) 121
capecitabine (120) 120
pertuzumab (116) 116
protein kinase inhibitors - pharmacology (115) 115
drug therapy (112) 112
neoplasms (111) 111
metastatic breast cancer (110) 110
drug resistance, neoplasm (107) 107
kinases (107) 107
male (106) 106
protein kinase inhibitors - therapeutic use (104) 104
analysis (103) 103
egfr (103) 103
erbb-2 protein (101) 101
mice (100) 100
tyrosine (100) 100
tumors (95) 95
cancer therapies (92) 92
signal transduction - drug effects (91) 91
hematology, oncology and palliative medicine (88) 88
drug resistance (86) 86
antibodies, monoclonal, humanized (85) 85
antineoplastic combined chemotherapy protocols - adverse effects (83) 83
cell biology (83) 83
antineoplastic agents - adverse effects (81) 81
disease-free survival (81) 81
health aspects (80) 80
clinical trials (79) 79
cell proliferation - drug effects (78) 78
receptor, epidermal growth factor - antagonists & inhibitors (78) 78
apoptosis (74) 74
bevacizumab (74) 74
neoplasm metastasis (73) 73
antineoplastic agents - administration & dosage (72) 72
deoxycytidine - analogs & derivatives (72) 72
antibodies, monoclonal, humanized - therapeutic use (69) 69
biochemistry & molecular biology (68) 68
proteins (67) 67
aged, 80 and over (66) 66
signal transduction (66) 66
antibodies, monoclonal - therapeutic use (65) 65
gefitinib (65) 65
erbb2 (63) 63
breast neoplasms - mortality (62) 62
protein kinase inhibitors - administration & dosage (62) 62
apoptosis - drug effects (61) 61
deoxycytidine - administration & dosage (61) 61
fluorouracil - analogs & derivatives (61) 61
targeted therapy (61) 61
quinazolines - pharmacokinetics (60) 60
erlotinib (59) 59
molecular targeted therapy (59) 59
mutation (59) 59
cancer research (58) 58
fluorouracil - administration & dosage (58) 58
neoplasms. tumors. oncology. including cancer and carcinogens (57) 57
prognosis (56) 56
development and progression (55) 55
xenograft model antitumor assays (55) 55
antibodies, monoclonal, humanized - administration & dosage (54) 54
brain neoplasms - secondary (54) 54
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1304) 1304
French (19) 19
Japanese (15) 15
Chinese (10) 10
German (9) 9
Czech (6) 6
Russian (5) 5
Polish (4) 4
Portuguese (3) 3
Spanish (3) 3
Turkish (3) 3
Hungarian (2) 2
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Breast cancer research and treatment, ISSN 1573-7217, 12/2017, Volume 168, Issue 3, pp. 631 - 638
Journal Article
Cellular and molecular life sciences : CMLS, ISSN 1420-9071, 01/2019, Volume 76, Issue 6, pp. 1185 - 1199
Receptor tyrosine kinases (RTKs) play key roles in various aspects of cell biology, including cell-to-cell communication, proliferation and differentiation,... 
Life Sciences | Biomedicine, general | Biochemistry, general | Life Sciences, general | Cell-based assay | Lapatinib | Receptor tyrosine kinases | TEV protease | Split TEV recruitment assay | Cell Biology | Biochemistry & Molecular Biology | Life Sciences & Biomedicine | Science & Technology | A549 Cells | Reproducibility of Results | ErbB Receptors - antagonists & inhibitors | ErbB Receptors - metabolism | Humans | ErbB Receptors - genetics | Rats | Biological Assay - methods | Pyrimidines - pharmacology | Receptor Protein-Tyrosine Kinases - metabolism | PC12 Cells | Pyrimidines - metabolism | src Homology Domains | Lapatinib - pharmacology | Animals | Lapatinib - metabolism | Receptor Protein-Tyrosine Kinases - genetics | GRB2 Adaptor Protein - genetics | Protein Binding - drug effects | Cell Line, Tumor | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Acrylamides - metabolism | GRB2 Adaptor Protein - metabolism | Acrylamides - pharmacology | Tyrosine | Epidermal growth factor | Proteases | Detectors | Phenols | Psychotherapy | Cells | Phosphotyrosine | Homeostasis | High-throughput screening | Homology | Antagonists | Neurodevelopmental disorders | Cell interactions | Kinases | Assaying | Recruitment | Proteins | Genetic code | Coding | Growth factors | Adaptor proteins | Cell survival | Hepatocyte growth factor | ErbB protein | Adapters | Pharmacology | Insulin | Grb2 protein | Domains | Ligands | Receptor mechanisms | Biosensors | Adapter proteins | Cancer | Index Medicus | Original
Journal Article
Journal Article
Current pharmacogenomics and personalized medicine, ISSN 1875-6921, 2011, Volume 9, Issue 3, pp. 184 - 190
Journal Article
Journal of clinical oncology, ISSN 0732-183X, 04/2015, Volume 33, Issue 12, pp. 1334 - 1339
Journal Article
Oncotarget, ISSN 1949-2553, 01/2019, Volume 10, Issue 9, pp. 926 - 929
A complete oncofertility counselling should be offered to all premenopausal patients before the administration of anticancer treatments. This important... 
Breast cancer | Lapatinib | HER2 | Fertility | Trastuzumab
Journal Article
The lancet oncology, ISSN 1470-2045, 06/2017, Volume 18, Issue 6, pp. 732 - 742
Summary Background The antibody–drug conjugate trastuzumab emtansine is indicated for the treatment of patients with HER2-positive metastatic breast cancer... 
Hematology, Oncology and Palliative Medicine | Life Sciences & Biomedicine | Oncology | Science & Technology | Capecitabine - administration & dosage | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Response Evaluation Criteria in Solid Tumors | Antineoplastic Agents - therapeutic use | Hand-Foot Syndrome - etiology | Diarrhea - chemically induced | Young Adult | Breast Neoplasms - chemistry | Antineoplastic Agents - adverse effects | Aged, 80 and over | Adult | Female | Quinazolines - administration & dosage | Lapatinib | Antibodies, Monoclonal, Humanized - adverse effects | Maytansine - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Maytansine - analogs & derivatives | Anemia - chemically induced | Survival Rate | Thrombocytopenia - chemically induced | Trastuzumab - administration & dosage | Breast Neoplasms, Male - drug therapy | Maytansine - therapeutic use | Breast Neoplasms - drug therapy | Breast Neoplasms, Male - chemistry | Disease-Free Survival | Retreatment | Taxoids - administration & dosage | Vomiting - chemically induced | Aspartate Aminotransferases - blood | Capecitabine - adverse effects | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - pathology | Quinazolines - adverse effects | Aged | Breast Neoplasms, Male - pathology | Receptor, ErbB-2 - analysis | Bridged-Ring Compounds - administration & dosage | Care and treatment | Breast cancer | Metastasis | Patient outcomes | Analysis | Index Medicus
Journal Article
Journal Article